Aviva’s Amphenol APH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$186M Buy
2,111,154
+56,670
+3% +$4.08M 0.27% 68
2026
Q1
$130M Buy
2,054,484
+62,408
+3% +$4.39M 0.22% 84
2025
Q4
$135M Buy
1,992,076
+113,464
+6% +$7.59M 0.23% 88
2025
Q3
$116M Buy
1,878,612
+163,330
+10% +$8.96M 0.21% 95
2025
Q2
$84.7M Buy
1,715,282
+1,049,904
+158% +$42.9M 0.17% 121
2025
Q1
$21.8M Buy
665,378
+86,210
+15% +$2.94M 0.05% 329
2024
Q4
$20.1M Sell
579,168
-20,696
-3% -$724K 0.05% 322
2024
Q3
$19.5M Sell
599,864
-600,240
-50% -$19.5M 0.05% 345
2024
Q2
$40.4M Buy
1,200,104
+208,676
+21% +$6.58M 0.11% 214
2024
Q1
$28.6M Buy
991,428
+238,620
+32% +$6.25M 0.09% 256
2023
Q4
$18.7M Sell
752,808
-91,968
-11% -$2.03M 0.07% 343
2023
Q3
$17.7M Buy
844,776
+563,436
+200% +$12.1M 0.07% 341
2023
Q2
$5.97M Buy
281,340
+29,096
+12% +$565K 0.02% 486
2023
Q1
$5.15M Sell
252,244
-172,512
-41% -$3.41M 0.02% 555
2022
Q4
$8.09M Sell
424,756
-32,624
-7% -$617K 0.04% 494
2022
Q3
$7.66M Buy
457,380
+126,836
+38% +$2.3M 0.04% 487
2022
Q2
$5.32M Sell
330,544
-133,112
-29% -$2.31M 0.03% 575
2022
Q1
$8.73M Sell
463,656
-250,768
-35% -$4.86M 0.04% 458
2021
Q4
$15.6M Sell
714,424
-92
-0% -$1.86K 0.07% 285
2021
Q3
$13.1M Sell
714,516
-38,144
-5% -$700K 0.06% 331
2021
Q2
$12.9M Sell
752,660
-99,488
-12% -$1.68M 0.06% 324
2021
Q1
$14.1M Sell
852,148
-14,980
-2% -$243K 0.07% 260
2020
Q4
$14.2M Sell
867,128
-52,152
-6% -$801K 0.07% 249
2020
Q3
$12.4M Sell
919,280
-42,536
-4% -$560K 0.07% 232
2020
Q2
$11.5M Sell
961,816
-251,560
-21% -$2.81M 0.07% 237
2020
Q1
$11.1M Buy
1,213,376
+245,712
+25% +$2.93M 0.08% 211
2019
Q4
$13.1M Buy
967,664
+146,240
+18% +$1.87M 0.08% 225
2019
Q3
$9.91M Sell
821,424
-46,560
-5% -$537K 0.07% 259
2019
Q2
$10.4M Sell
867,984
-24,664
-3% -$297K 0.07% 263
2019
Q1
$10.5M Buy
892,648
+8,736
+1% +$97.7K 0.07% 270
2018
Q4
$8.95M Sell
883,912
-4,461,448
-83% -$47.9M 0.07% 280
2018
Q3
$62.8M Sell
5,345,360
-52,072
-1% -$605K 0.34% 75
2018
Q2
$58.8M Sell
5,397,432
-1,683,480
-24% -$18.3M 0.35% 71
2018
Q1
$76.2M Buy
7,080,912
+1,499,280
+27% +$16.9M 0.47% 51
2017
Q4
$61.3M Buy
5,581,632
+31,952
+0.6% +$351K 0.35% 66
2017
Q3
$58.7M Sell
5,549,680
-1,040
-0% -$10.2K 0.32% 75
2017
Q2
$51.2M Buy
5,550,720
+208,000
+4% +$1.9M 0.29% 82
2017
Q1
$47.5M Buy
5,342,720
+2,446,160
+84% +$21.2M 0.27% 87
2016
Q4
$24.3M Sell
2,896,560
-457,464
-14% -$3.81M 0.15% 156
2016
Q3
$27.2M Sell
3,354,024
-344,944
-9% -$2.62M 0.17% 127
2016
Q2
$26.5M Buy
3,698,968
+2,436,480
+193% +$17.5M 0.18% 125
2016
Q1
$9.13M Buy
1,262,488
+17,088
+1% +$111K 0.07% 319
2015
Q4
$8.13M Sell
1,245,400
-3,504
-0.3% -$23.4K 0.06% 337
2015
Q3
$7.96M Sell
1,248,904
-32,040
-3% -$215K 0.07% 318
2015
Q2
$9.28M Sell
1,280,944
-42,800
-3% -$307K 0.07% 319
2015
Q1
$9.75M Buy
1,323,744
+283,664
+27% +$1.99M 0.07% 342
2014
Q4
$7M Sell
1,040,080
-7,600
-0.7% -$48.6K 0.05% 382
2014
Q3
$6.54M Sell
1,047,680
-3,520
-0.3% -$22.1K 0.05% 404
2014
Q2
$6.33M Sell
1,051,200
-11,200
-1% -$66.7K 0.05% 429
2014
Q1
$6.09M Buy
1,062,400
+52,800
+5% +$294K 0.05% 410
2013
Q4
$5.63M Buy
1,009,600
+34,304
+4% +$177K 0.05% 415
2013
Q3
$4.72M Buy
975,296
+195,728
+25% +$956K 0.04% 432
2013
Q2
$3.8M Buy
+779,568
New +$3.73M 0.04% 426

Other funds holding APH

Aviva's APH Position: Q2 2026 in Review

Aviva increased its Amphenol (APH) stake by 2.8% in Q2 2026, buying an estimated $4.08M and bringing the position to 2,111,154 shares worth $186M. The position accounts for 0.27% of the portfolio, ranked #68.

Aviva first reported a position in APH in Q2 2013 and has held it in 53 quarters since. 2,340 funds tracked by Wall St. Rank hold APH as of Q2 2026.

  • Aviva held 2,111,154 shares of Amphenol worth $186M as of Q2 2026.
  • Aviva bought 56,670 Amphenol shares in Q2 2026, an estimated $4.08M.
  • Amphenol made up 0.27% of Aviva's portfolio in Q2 2026, its #68 holding.
  • Aviva first reported a position in Amphenol in Q2 2013 and has held it in 53 quarters since.
  • 2,340 funds tracked by Wall St. Rank held Amphenol as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.